Corcept Therapeutics, Inc. (CORT)
85.28
+2.14
(+2.57%)
USD |
NASDAQ |
Dec 10, 16:00
85.28
0.00 (0.00%)
After-Hours: 18:28
Corcept Therapeutics Market Cap: 8.971B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.78B |
| Gilead Sciences, Inc. | 150.58B |
| LeMaitre Vascular, Inc. | 1.899B |
| United Therapeutics Corp. | 20.87B |
| Vertex Pharmaceuticals, Inc. | 112.79B |
Market Cap Related Metrics
| PE Ratio | 97.45 |
| PS Ratio | 13.76 |
| Price to Book Value | 14.20 |
| Price to Free Cash Flow | 62.72 |
| Price | 85.28 |
| Earnings Yield | 1.03% |
| Operating PE Ratio | 155.49 |
| Normalized PE Ratio | 97.45 |